Malvern, United States
Phanes Biotech is an early-stage biotechnology company founded in 2020, with a primary focus on developing molecules to address neurodegenerative diseases and developmental disabilities through neural regeneration. The company's mission is encapsulated in its slogan: "Shifting the balance from NeuroDegeneration to NeuroRegeneration." Recognizing the growing demand for innovative solutions in the Health Care sector, Phanes Biotech aims to pioneer advancements in the treatment paradigm for neurodegenerative conditions.
By targeting neuroregeneration and exploring tau immunotherapy for tauopathies, Phanes Biotech demonstrates a commitment to exploring diverse avenues for tackling these complex conditions. Through its dedication to drug development, the company strives to offer a new hope for patients and caregivers impacted by these challenging diseases.
Currently, Phanes Biotech does not have publicly disclosed information regarding its headquarters or recent investments and investors. However, its ambitious mission and focus on a rapidly growing industry position it as a compelling prospect for potential venture capital interest.
